Trademark: 88182290
Word
RIABNI
Status
Registered
Status Code
700
Status Date
Tuesday, August 2, 2022
Serial Number
88182290
Registration Number
6809212
Registration Date
Tuesday, August 2, 2022
Mark Type
4000
Filing Date
Monday, November 5, 2018
Published for Opposition
Tuesday, September 10, 2019

Trademark Owner History
Amgen Inc. - Original Registrant

Classifications
5 Pharmaceutical preparations for treatment of inflammatory and auto-immune diseases and disorders; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the immune system and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), and microscopic polyangiitis (MPA)

Trademark Events
Aug 2, 2022
Notice Of Registration Confirmation Emailed
Aug 2, 2022
Registered-Principal Register
Jun 25, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 24, 2022
Allowed Principal Register - Sou Accepted
Jun 21, 2022
Statement Of Use Processing Complete
Jun 16, 2022
Use Amendment Filed
Jun 16, 2022
Teas Statement Of Use Received
May 3, 2022
Notice Of Approval Of Extension Request E-Mailed
May 2, 2022
Sou Extension 5 Granted
Apr 26, 2022
Sou Extension 5 Filed
May 2, 2022
Case Assigned To Intent To Use Paralegal
Apr 26, 2022
Teas Extension Received
Sep 18, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 16, 2021
Sou Extension 4 Granted
Sep 16, 2021
Sou Extension 4 Filed
Sep 16, 2021
Teas Extension Received
May 6, 2021
Teas Change Of Correspondence Received
May 6, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
May 6, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
May 6, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 7, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 5, 2021
Sou Extension 3 Granted
Apr 5, 2021
Sou Extension 3 Filed
Apr 5, 2021
Teas Extension Received
Oct 31, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 29, 2020
Sou Extension 2 Granted
Oct 29, 2020
Sou Extension 2 Filed
Oct 29, 2020
Teas Extension Received
Apr 30, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 28, 2020
Sou Extension 1 Granted
Apr 28, 2020
Sou Extension 1 Filed
Apr 28, 2020
Teas Extension Received
Nov 5, 2019
Noa E-Mailed - Sou Required From Applicant
Sep 10, 2019
Official Gazette Publication Confirmation E-Mailed
Sep 10, 2019
Published For Opposition
Aug 21, 2019
Notification Of Notice Of Publication E-Mailed
Aug 8, 2019
Assigned To Lie
Jul 29, 2019
Approved For Pub - Principal Register
Jul 25, 2019
Examiner's Amendment Entered
Jul 25, 2019
Notification Of Examiners Amendment E-Mailed
Jul 25, 2019
Examiners Amendment E-Mailed
Jul 25, 2019
Examiners Amendment -Written
Mar 7, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 7, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 13, 2018
Notification Of Priority Action E-Mailed
Dec 13, 2018
Priority Action E-Mailed
Dec 13, 2018
Priority Action Written
Dec 11, 2018
Assigned To Examiner
Nov 20, 2018
New Application Office Supplied Data Entered
Nov 8, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24